What type of Computed Tomography (CT) is ordered to rule out Pulmonary Embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To rule out pulmonary embolism (PE), a CT pulmonary angiogram (CTPA) is the preferred imaging study. This recommendation is based on the evidence from the American College of Physicians [ 1 ], which suggests that CTPA is the most appropriate imaging test for patients with a high pretest probability of PE. The use of CTPA has been shown to have a high sensitivity and specificity for detecting PE, and it is able to identify alternative diagnoses that may explain the patient's symptoms [ 1 ].

Key Points to Consider

  • CTPA uses intravenous contrast material to visualize the pulmonary arteries and detect filling defects caused by blood clots.
  • The procedure typically takes about 15-30 minutes to complete, with the actual scanning time being only a few minutes.
  • Patients will need to have an IV placed for contrast administration and may be asked to hold their breath briefly during the scan.
  • CTPA has largely replaced ventilation-perfusion (V/Q) scans as the first-line imaging test for suspected PE due to its higher sensitivity and specificity.
  • Patients with impaired kidney function may require special consideration regarding contrast use, and those with severe contrast allergies may need pre-medication or alternative imaging approaches.

Clinical Considerations

  • The clinical probability of PE should be assessed using validated clinical prediction rules, such as the Wells rule or the Geneva rule [ 1 ].
  • Patients with a low or intermediate pretest probability of PE may undergo a high-sensitivity d-dimer measurement as the initial diagnostic test [ 1 ].
  • The use of age-adjusted d-dimer thresholds may be considered in patients older than 50 years [ 1 ].

Recent Guidelines

  • The American College of Radiology Appropriateness Criteria recommend CTPA as the preferred imaging study for suspected PE [ 1 ].
  • The European Society of Cardiology guidelines also recommend CTPA as the first-line imaging test for suspected PE [ 1 ].

From the Research

Computed Tomography for Pulmonary Embolism

  • Computed Tomography Pulmonary Angiography (CTPA) is the imaging test of first choice to rule out Pulmonary Embolism (PE) 2, 3, 4.
  • CTPA has been shown to have a high sensitivity and specificity for the diagnosis of pulmonary embolism 2, 3, 5.
  • The presence or absence of pulmonary embolism can be determined with sufficient certainty without the need for additional imaging tests after a negative CTPA 2, 3, 5.

Alternative Imaging Modalities

  • Ventilation-perfusion scintigraphy is reserved for patients with a stringent contraindication for CTPA 2.
  • Compression ultrasonography is reserved for patients with concomitant symptomatic deep vein thrombosis 2.
  • Magnetic Resonance Pulmonary Angiography is not a suitable alternative for CTPA 2.
  • Single Photon Emission Tomography (SPECT) V/Q scanning offers a nuclear medicine modality that is an alternative to CTPA in at least some patients with suspected pulmonary embolism at a fraction of the risk of radiation exposure 3.

Diagnostic Algorithms

  • Diagnostic algorithms using CTPA or V/Q scanning have proven to be comparably safe to exclude the diagnosis of pulmonary embolism 3, 5.
  • Excluding low-risk patients for pulmonary embolism as defined by clinical scoring systems and D-dimer testing would enhance the yield of diagnostic testing 3, 5.
  • CTPA is the most reliable test for diagnosis of pulmonary embolism, but diagnostic algorithms using V/Q scanning may be preferred in some patient populations 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.